Bloomberg Crispr Therapeutics AG plunged after the gene-editing company said a planned trial of its treatment to help people with sickle-cell disease was being put on hold by US regulators. Crispr is developing the therapy with Vertex Pharmaceuticals Inc., and the trial had yet to begin. The companies said in a statement that the Food and Drug Administration placed a ...

If you’re nostalgic for the 2008-09 financial crisis, you can cheer up. Another debacle may be on its way. Its epicenter would be Italy, which may threaten the rest of the world economy. Under the worst-case assumptions, Italy could abandon the euro — the single currency now used by 19 countries — and experience a full-blown financial meltdown that would ...

From the beginning of Donald Trump’s presidential campaign, he has said he wants to make trade “fair.” For too long, he argued, American companies and workers suffered as trading partners used tactics that stole jobs, damaged US industry and widened deficits. The implication was that he’d work to strip away the remaining tariffs and other hurdles that tilted the playing ...